Neovasc (NVCN) Upgraded by Zacks Investment Research to Hold

Neovasc stock has undergone multiple analysts rating changes in the recent past.  Neovasc Upgraded by Zacks Investment Research on 10/13/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

Shares of Neovasc traded down -$0.01 on Tuesday, reaching $0.68. 960 shares of the stock traded hands, compared to its average volume of 454127. Shares of Neovasc were trading at $0.68 on Tuesday. The firm’s 50 day moving average is $0.77 and its 200 day moving average is $1.01.Neovasc has a 12 month low of $0.67 and a 12 month high of $2.66. While on yearly highs and lows, Neovasc’s today has traded high as $0.70 and has touched $0.67 on the downward trend. See More Analyst Rating at: RATING

Neovasc Earnings and What to expect: 

Neovasc last released its quarterly earnings data on August 10th, 2021. The medical equipment provider reported ($0.09) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.09). The business earned $0.63 million during the quarter, compared to the consensus estimate of $1 million. Neovasc has generated ($1.71) earnings per share over the last year (($0.86) diluted earnings per share). Earnings for Neovasc are expected to grow in the coming year, from ($0.36) to ($0.08) per share. Neovasc has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, November 4th, 2021 based off prior year’s report dates.

Earnings for Neovasc are expected to grow in the coming year, from ($0.36) to ($0.08) per share. The P/E ratio of Neovasc is -0.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Neovasc is -0.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Neovasc has a P/B Ratio of 9.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Neovasc (NVCN) Moving Average Technical Analysis

5 day Moving Average is $0.69 And 5 day price change is -$0.01 (-1.50%)  with average volume for 5 day average is 354,360. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $0.72 and 20 day price change is -$0.07 (-8.99%) and average 20 day moving volume is 543,165. 50 day moving average is $0.77  and 50 day price change is -$0.17 ( -19.94%)  and with average volume for 50 days is : 444,328. 200 day moving average is $1.01  and 200 day price change is -$0.34 (-33.08%)  and with average volume for 200 days is : 2,447,282.

Other owners latest trading in Neovasc :

  • On 8/17/2021 shares held by Citadel Advisors LLC were 118,434 which equates to market value of $0.11M and appx 0.00% owners of Neovasc
  • On 8/16/2021 shares held by Goldman Sachs Group Inc. were 75,700 which equates to market value of $70K and appx 0.00% owners of Neovasc
  • On 7/28/2021 shares held by Usca Ria LLC were 300,000 which equates to market value of $0.28M and appx 0.00% owners of Neovasc
  • In total Institutional ownership equates to Institutional Ownership Percentage: 2.42% for Neovasc

See More Analyst Rating at: RATING